HOSPIRA HYOSCINE HYDROBROMIDE INJECTION hyoscine hydrobromide (as trihydrate) 400 microgram/1mL injection ampoule

देश: ऑस्ट्रेलिया

भाषा: अंग्रेज़ी

स्रोत: Department of Health (Therapeutic Goods Administration)

सक्रिय संघटक:

hyoscine hydrobromide

थमां उपलब्ध:

Pfizer Australia Pty Ltd

INN (इंटरनेशनल नाम):

Hyoscine hydrobromide

प्राधिकरण का दर्जा:

Registered

सूचना पत्रक

_____________________________________________________________________________________________________
Superseded: N/A
Version: pfchyos11019
HOSPIRA
™ HYOSCINE HYDROBROMIDE INJECTION
Hyoscine hydrobromide (_HYE-oh-seen HYE-droe BROE-mide_)
CONSUMER MEDICINE INFORMATION
_Date of Dispensing _
_Consumer Name _
_Pharmacist Name _
_Consumer Address _
_Pharmacist Address_
WHAT IS IN THIS LEAFLET
This leaflet answers some common questions about Hospira
™
Hyoscine Hydrobromide
Injection (hyoscine). It does not contain all the available
information.
It does not take the place of talking to your doctor and pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risks of you being given
Hospira
™
Hyoscine Hydrobromide Injection against the benefits this medicine is
expected to
have for you.
IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET IN A SAFE PLACE.
You may need to read it again.
WHAT HOSPIRA
™ HYOSCINE HYDROBROMIDE INJECTIONIS USED FOR
Hospira
™
Hyoscine Hydrobromide Injection is used before surgery to make you
drowsy and
forgetful, and to reduce the amount of saliva and some fluids you
produce in your lungs. It is
also used to treat nausea and vomiting from motion sickness.
Hyoscine works by acting directly on your brain, salivary glands and
air passages to reduce
nerve impulses and slow down the activity of these areas.
Your doctor may have prescribed
Hospira
™
Hyoscine Hydrobromide Injection for another
reason. Ask your doctor if you have any questions about why this
medicine has been
prescribed for you.
BEFORE YOU ARE GIVEN HOSPIRA
™ HYOSCINE HYDROBROMIDE INJECTION
_WHEN YOU MUST NOT BE GIVEN IT _
HOSPIRA
™ HYOSCINE HYDROBROMIDE INJECTION SHOULD NOT BE GIVEN TO YOU IF:
•
YOU HAVE AN ALLERGY TO HYOSCINE.
Some of the symptoms of an allergic reaction to hyoscine may include
skin rash, itching,
difficulty breathing and swelling, especially of the face and throat.
•
THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING
•
THE EXPIRY D

उत्पाद विशेषताएं

Version: pfphyosi11019
Supersedes: Version 1.0
Page 1 of 8
AUSTRALIAN
PRODUCT
INFORMATION
–
HOSPIRA™
HYSOCINE
HYDROBROMIDE
INJECTION (HYOSCINE HYDROBROMIDE)
1.
NAME OF THE MEDICINE
Hyoscine hydrobromide
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Hospira™ Hyoscine Hydrobromide Injection contains 400 µg of
hyoscine hydrobromide per
1 mL. The pH of the solution is between 3.8 and 4.2.
For the full list of excipients, see Section 6.1 List of excipients.
3.
PHARMACEUTICAL FORM
Solution for injection
Hospira™ Hyoscine Hydrobromide Injection is a clear, colourless to
straw coloured, sterile
solution.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Hospira™ Hyoscine Hydrobromide Injection is indicated as a
pre-operative medication to
produce sedation and amnesia. It is also used pre-operatively to
inhibit salivation and excessive
secretions of the respiratory tract.
Hospira™ Hyoscine Hydrobromide Injection is also indicated for the
treatment of selected
cases of nausea and vomiting resulting from motion sickness, although
oral or transdermal
administration is more frequently used for this indication.
4.2 DOSE AND METHOD OF ADMINISTRATION
DOSAGE
Hospira™
Hyoscine
Hydrobromide
Injection
is
administered
by
the
intramuscular,
subcutaneous or intravenous injection. When given intravenously, the
drug should be diluted
with sterile Water for injections and injected slowly with caution.
When used for pre-operative medication, hyoscine hydrobromide should
be administered 30 to
60 minutes prior to induction of anaesthesia.
_Adult dose: _
The usual adult dose is 0.3 to 0.6 mg given IM, SC, or IV. This dose
may be
repeated 3 to 4 times a day. When used as an antiemetic, doses up to 1
mg have been
Version: pfphyosi11019
Supersedes: Version 1.0
Page 2 of 8
administered. A reduced dosage may be required in elderly or
debilitated patients or those with
hepatic or renal insufficiency.
_Paediatric _
_dose: _
The
usual
paediatric
dose
is
6
microgram/kg
body
weight,
or
200 microgram/m
2
surface area, IM, SC, or IV.
COMPA